Innovative Pharmaceutical Biotech logo

399 - Innovative Pharmaceutical Biotech Share Price

HK$0.295 -0.0  -1.7%

Last Trade - 8:08am

Sector
Industrials
Size
Micro Cap
Market Cap £43.7m
Enterprise Value £194.0m
Revenue £1.85m
Position in Universe 4100th / 5919
Bullish
Bearish
Unlock 399 Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

399 Revenue Unlock 399 Revenue

Net Income

399 Net Income Unlock 399 Revenue

Normalised EPS

399 Normalised EPS Unlock 399 Revenue

PE Ratio Range

399 PE Ratio Range Unlock 399 Revenue

Dividend Yield Range

399 Dividend Yield Range Unlock 399 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
399 EPS Forecasts Unlock 399 Revenue
Profile Summary

Innovative Pharmaceutical Biotech Limited is a Hong Kong-based investment holding company principally engaged in pharmaceuticals and biotechnology businesses. The Company operates through five segments. Genetic Testing Services segment is engaged in the provision of genetic testing services in the People’s Republic of China (PRC) and Hong Kong. Bio-Industrial Products segment is engaged in the distribution of bio-industrial products in the PRC. Beauty Equipment and Products segment is engaged in the trading of beauty equipment and products in Hong Kong. Securities Investment segment is engaged in securities investment in Hong Kong and outside Hong Kong. Research and Development segment is engaged in the research, development and commercialization of the oral insulin products.

Directors
Last Annual March 31st, 2019
Last Interim March 31st, 2019
Incorporated March 1, 2013
Public Since July 18, 2008
No. of Shareholders: n/a
No. of Employees: 23
Sector Industrials
Industry Machinery, Equipment & Components
Index
Exchange Stock Exchange of Hong Kong Limited
Shares in Issue 1,464,193,024
Free Float (0.0%)
Eligible for
ISAs
SIPPs
399 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 399
Upcoming Events for 399
Similar to 399
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.